Septodont Announces Karim Khadr as New Division President

Posted on July 26, 2021

Paris, France – Septodont, the world leader in dental anesthesia, announced today that Karim Khadr will join the company as President of its dental division, on July 28. He will report to Olivier Schiller, CEO of the Septodont Group.

Karim joins Septodont with over 30 years of experience, serving in various sales, marketing, business development and product management functions, in both large and small organizations in the medical devices and diagnostics industry.

As the President of Septodont’s dental division, Karim will have direct responsibility for the company’s global dental business, responding to rapidly changing market trends. He will be focusing on effectively managing our sales and marketing organizations across the world and will also be responsible for leading the group’s innovation agenda.

“This is an exciting appointment for our company. Karim brings a strong track record of driving results and accelerating growth in a number of different healthcare segments”, said Olivier Schiller, CEO of the Septodont Group. He is a well-rounded leader. His extensive experience combined with his strong global background position him well to lead our dental division and build on the company’s momentum in the Pain Management and Therapeutics areas to continue to grow the legacy of our family-owned business.”

“I’m excited to step into this new Executive leadership role at Septodont and help the company continue executing its strategic plan. They have already accomplished so much over the years as the world leader in dental anesthesia. I look forward to working with the entire team at Septodont and partnering with all of our customers worldwide to drive the company’s next phase of global growth with further opportunities ahead”, said Karim.

Karim is an alumnus of Kelley School of Business, Indiana University, Bloomington, where he earned a Bachelor of Science and an MBA.

About Septodont

Septodont is a leading manufacturer of dental pharmaceuticals and medical devices. Since its inception in 1932, the group develops, produces and distributes a large range of products and solutions dedicated to serving the needs of dental professionals across the world. The group counts 1,900 employees and has a long-established presence in more than 150 countries. Beyond dental and through its Novocol Pharma division, the group also partners with pharmaceutical and medical device companies to provide contract manufacturing services for pharmaceutical products that require cartridge filling. Learn more about Septodont’s innovative, safe and healthcare solutions at https://www.septodontcorp.com/.

© 2021 AEGIS Communications | Privacy Policy